# Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)

> **NCT00077818** · PHASE4 · COMPLETED · sponsor: **Sanofi**

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Enoxaparin sodium

## Key facts

- **NCT ID:** NCT00077818
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2005-02
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077818, "Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00077818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*